Should You Be Adding Afya (NASDAQ:AFYA) To Your Watchlist Today?
BofA Securities Maintains Afya Ltd(AFYA.US) With Buy Rating, Announces Target Price $25
Morgan Stanley Maintains Afya Ltd(AFYA.US) With Hold Rating, Maintains Target Price $18
Here's Why AFYA (AFYA) Lagged in Q3
BofA Securities Maintains Afya Ltd(AFYA.US) With Buy Rating
Afya Limited's (NASDAQ:AFYA) Intrinsic Value Is Potentially 98% Above Its Share Price
Afya Limited's (NASDAQ:AFYA) Shares Not Telling The Full Story
Afya Limited to Host Afya Day 2024 on October 29th | Hybrid Event
Here's Why Afya (NASDAQ:AFYA) Can Manage Its Debt Responsibly
Afya Limited Announces MEC Decision on Medical Seats Reconsideration in Unigranrio
Express News | Afya - Ministry of Education Granted Request for Reconsideration Submitted by Universidade Do Grande Rio Professor Jos*De Souza Herdy
Express News | Afya Ltd - Announces Mec Decision on Medical Seats Reconsideration in Unigranrio
Afya Secures Full Disbursement of R$500 Million From IFC to Support the Company's Expansion
Afya Initiated at Neutral by UBS
Afya Price Target Announced at $19.50/Share by UBS
Express News | UBS Initiates Coverage On Afya With Neutral Rating, Announces Price Target of $19.5
Afya Analyst Ratings
What Does Afya Limited's (NASDAQ:AFYA) Share Price Indicate?
Afya Up Over 8%, On Track for Largest Percent Increase Since December 2022 -- Data Talk
Express News | Afya Shares Are Trading Higher After the Company Reported a Year-over-year Increase in Q2 Financial Results